Probiotics improve symptoms of patients with COVID-19 through gut-lung axis: a systematic review and meta-analysis

Y Tian, H Ran, X Wen, G Fu, X Zhou, R Liu… - Frontiers in Nutrition, 2023 - frontiersin.org
Background Multi system symptoms such as gastrointestinal tract and respiratory tract exist
in coronavirus disease 2019 (COVID-19) patients. There is a lack of reliable evidence to …

Benefits of probiotic use on COVID-19: A systematic review and meta-analysis

S Neris Almeida Viana… - Critical Reviews in …, 2024 - Taylor & Francis
SARS-CoV-2 is the virus that causes the new global pandemic, which has already resulted
in millions of deaths, affecting the world's health and economy. Probiotics have shown …

Safety and efficacy of probiotic supplements as adjunctive therapies in patients with COVID-19: a systematic review and meta-analysis

J Zhu, T Pitre, C Ching, D Zeraatkar, S Gruchy - PLoS One, 2023 - journals.plos.org
Background and aims Oral probiotic supplementation may be a beneficial adjunctive
therapy for patients with symptomatic COVID-19. However, its safety and efficacy are …

Clinical efficacy of probiotics in the treatment of patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials

JY Wu, PY Huang, TH Liu, CY Kuo… - Expert Review of Anti …, 2023 - Taylor & Francis
Objectives This study was conducted to assess the clinical efficacy of probiotics in the
treatment of patients with COVID19. Methods PubMed, Embase, Cochrane Library, and …

Probiotic supplementation: a prospective approach in the treatment of COVID-19

A Nayebi, JG Navashenaq, D Soleimani… - Nutrition and …, 2022 - journals.sagepub.com
Background: Despite strategies based on social distancing, the coronavirus disease 2019
(COVID-19) expands globally, and so far, many attempts have been made to achieve …

Probiotics as adjunctive treatment for patients contracted COVID-19: current understanding and future needs

J Peng, M Zhang, G Yao, LY Kwok, W Zhang - Frontiers in Nutrition, 2021 - frontiersin.org
The coronavirus disease 2019 (COVID-19) is caused by a novel coronavirus, severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), which rages all over the world and …

[HTML][HTML] The effect of probiotics on respiratory tract infection with special emphasis on COVID-19: Systemic review 2010–20

A Darbandi, A Asadi, R Ghanavati, R Afifirad… - International Journal of …, 2021 - Elsevier
To evaluate the effects of probiotic on patient's respiratory tract infection (RTI), a systematic
review was conducted on randomized controlled trials (RCTs). PubMed, Google Scholar …

[HTML][HTML] Oral probiotics in coronavirus disease 2019: Connecting the gut–lung axis to viral pathogenesis, inflammation, secondary infection and clinical trials

P Baindara, R Chakraborty, ZM Holliday… - New microbes and new …, 2021 - Elsevier
Defined as helpful live bacteria that can provide medical advantages to the host when
administered in tolerable amounts, oral probiotics might be worth considering as a possible …

Gut dysbiosis during COVID-19 and potential effect of probiotics

YP Hung, CC Lee, JC Lee, PJ Tsai, WC Ko - Microorganisms, 2021 - mdpi.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), an RNA virus of the family
Coronaviridae, causes coronavirus disease 2019 (COVID-19), an influenza-like disease that …

Probiotics and prebiotics: potential prevention and therapeutic target for nutritional management of COVID-19?

KS Batista, JG de Albuquerque… - Nutrition research …, 2023 - cambridge.org
Scientists are working to identify prevention/treatment methods and clinical outcomes of
coronavirus disease 2019 (COVID-19). Nutritional status and diet have a major impact on …